Praemium (PPS) COMPANY REPORT. Quartermaster
|
|
- Judith Phillips
- 6 years ago
- Views:
Transcription
1 10 October 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.45 SNAPSHOT Monthly Turnover $9.2mn Market Cap $162mn Shares Issued 399.6mn 52-Week High $ Week Low $0.32 Sector Information Technology BUSINESS DESCRIPTION Praemium is a technology provider to the global wealth management sector. It provides technology platforms for investment and portfolio administration, separately managed accounts (SMAs) and financial planning. PPS administers over 300,000 client accounts, has over $80bn in assets under administration and has relationships with over 900 institutions. PPS has operations in Australia, Europe and Asia. 12-MONTH PRICE & VOLUME RESEARCH ANALYST Nicolas Burgess, CFA nburgess@baillieuholst.com.au Piers Flanagan pflanagan@baillieuholst.com.au Disclosure The author owns no shares in PPS. Praemium (PPS) COMPANY REPORT Quartermaster Overall: PPS has delivered 9% quarterly growth in funds under administration in 1Q18, maintaining recent strong momentum, with a record quarter of inflows for the Australian business. We reiterate a BUY. Funds under administration (FUA): PPS reported group FUA of $6.7bn, up 31% over the year and 9% over the quarter. In Australia, FUA increased to $4.3bn, up 30% over the year and 11% over the quarter. In the UK, FUA of $2.4bn was up 35% over the year and 6% over the quarter (34% and 4% respectively on a constant currency basis). Flows: Australia recorded gross inflows of $587m, a record quarter with even contribution between new and existing clients. UK gross inflows of $162m were the third highest on record but lower than the last couple of results given the quieter European holiday season (as expected). Other points: PPS s Australian Super SMA now has $716m in FUA and accounts for 17% of total Australian FUA. PPS s in-house investment management products and models continue to grow, up 53% over the year to 440m (A$753m). Meanwhile, PPS has flagged additional investment in technology, product, and sales and marketing to accelerate growth momentum. No quantification has been given, although this is a consistent theme from the company over the last two years. We note the recent hire (4 Oct) of a new Head of Product and Marketing. We make modest increases to our cost growth assumptions (see below) but generally we remain comfortable that our forecasts reflect the investment requirements of the business. Changes to EPS: We decrease our EPS forecasts by 1.5% and 0.5% in FY18F and FY19F respectively, adding $ m of investment which is largely offset by slightly better-than-expected revenue momentum. Our $0.58 price target remains unchanged. Investment view: PPS continues to show good momentum across new business flows and funds under administration. We reiterate a BUY rating. Key attributes of our investment thesis include a growing managed accounts market as retail investors switch from other fund structures; growth initiatives from higher margin products in international markets; new capabilities and scale following strategic acquisitions; and potential corporate appeal (wealth technology likely to be part of the next wave of financial service consolidation, in our view). Valuation is not demanding trading on an FY18F PE of 34x with a two-year EPS CAGR of 37%. INVESTMENT SUMMARY Year End: 30 June 2016 (A) 2017 (A) 2018 (E) 2019 (E) 2020 (E) Revenue $mn EBITDA $mn EBIT $mn Reported Profit $mn Adjusted Profit $mn EPS (Reported) EPS (Adjusted) EPS Growth % PER (Reported) x PER (Adjusted) x Dividend Yield % Franking % Baillieu Holst Ltd ABN Please read the disclaimer at the end of this report. Page 1
2 Financial summary Code: PPS Rating: BUY Analyst: Nicolas Burgess Price Target: $0.58 Date: 10 October, 2017 Upside/downside: 29.3% Share Price: $0.45 Valuation: $0.48 Market Capitalisation: $180m Valuation method: DCF / EV/EBITA Year End: 30 June Risk: High PROFIT & LOSS (A$m) FY16A FY17A FY18E FY19E FY20E EARNINGS FY16A FY17A FY18E FY19E FY20E Net revenue EPS - Underling cash (diluted) Operations EPS Growth - underlying 214% 76% 32% 41% 19% Gross Margin EPS - Reported (diluted) Costs Diluted shares (m) EBITDA DPS (cps) Depreciation & amortisation Payout Ratio 0% 0% 0% 49% 50% EBIT Franking 0% 0% 0% 0% 100% Other Net interest VALUATION FY16A FY17A FY18E FY19E FY20E PBT Underlying P/E (x) Tax EV/EBITDA (x) Minorities EV/EBIT (x) Reported NPAT Dividend Yield (%) 0.0% 0.0% 0.0% 2.0% 2.4% Price/Book (x) Add back: Price/NTA (x) Non-recurring items (net tax) Price/FCF Underlying cash profit GROWTH FY16A FY17A FY18E FY19E FY20E Revenue growth 20.1% 11.9% 19.1% 19.6% 10.8% BALANCE SHEET (A$m) FY16A FY17A FY18E FY19E FY20E Operating cost growth 1.6% 9.7% 14.9% 19.6% 10.8% Assets EBITDA growth 90.9% 50.0% 46.0% 42.7% 17.8% Cash PBT growth 8.1% 33.8% 221.2% 53.0% 24.3% Receivables Underlying NPAT growth % -22.6% 615.1% 53.0% 24.3% PPE Reported NPAT growth % 76.8% 32.7% 42.6% 19.6% Intangibles MARGINS & RETURNS FY16A FY17A FY18E FY19E FY20E Tax assets EBITDA Margin 14.3% 19.2% 23.5% 28.1% 29.9% Other assets EBIT Margin 11.4% 16.3% 20.6% 25.5% 27.4% Total Assets NPBT Margin 5.5% 6.6% 17.8% 22.7% 25.5% Liabilities ROIC 42.0% 26.4% 82.2% 194.1% 1127% Payables ROE 13.9% 23.7% 26.5% 30.8% 31.4% Debt ROA 18.3% 26.5% 34.3% 38.7% 36.5% Provisions Effective Tax Rate 49.5% 70.8% 35.0% 35.0% 35.0% Other liabilities Total Liabilities GEARING FY16A FY17A FY18E FY19E FY20E Equity Net Debt / (cash) (A$m) Share capital Enterprise value Retained earnings Net Debt/Equity (%) -64% -53% -71% -91% -102% Other equity EBITDA/Net interest na na na na na Total shareholders equity OPERATIONAL DATA FY16A FY17A FY18E FY19E FY20E Revenue by Product (A$m): BV per share (cps) Portfolio Services NTA per share (cps) SMA - Australia SMA - Intenational Financial Planning CASH FLOW (A$M) FY16A FY17A FY18E FY19E FY20E Corporate / other Cash at Start Group revenue Cash from from ops Growth 23.4% 17.6% 18.5% 19.0% 10.8% Capex Free cash flow Funds on Platform (A$bn): Free cash flow per share (cps) Australia Cash flow from investing International Cash flow from financing Group Cash at end Growth 25.2% 27.3% 36.1% 29.4% 26.5% GOCF / EBITDA 20% 76% 95% 95% 95% FCF / Underlying cash NPAT 23% 17% 132% 130% 128% Baillieu Holst Ltd ABN Please read the disclaimer at the end of this report. Page 2
3 Quartermaster Overall: PPS has delivered 9% quarterly growth in funds under administration, maintaining recent strong momentum. We reiterate a BUY. FIG.1: PPS 1Q18 FUNDS UNDER ADMINISTRATION AND FLOWS Source: Company reports Funds under administration (FUA): PPS reported group FUA of $6.7bn, up 31% over the year and 9% over the quarter. In Australia, FUA increased to $4.3bn, up 30% over the year and 11% over the quarter. In the UK, FUA of $2.4bn was up 35% over the year and 6% over the quarter (34% and 4% respectively on a constant currency basis). FIG.2: PPS 1Q18 FUNDS UNDER ADMINISTRATION AND FLOWS Source: Company reports Flows: Australia recorded gross inflows of $587m, a record quarter with even contribution between new and existing clients. UK gross inflows of $162m were the third highest on record but lower than the last couple of results given the quieter European holiday season (as expected). FIG.3: PPS IN-HOUSE INVESTMENT MANAGEMENT Source: Company reports Baillieu Holst Ltd ABN Please read the disclaimer at the end of this report. Page 3
4 Other points: PPS s Australian Super SMA now has $716m in FUA and accounts for 17% of total Australian FUA. PPS s in-house investment management products and models continue to grow, up 53% over the year to 440m (A$753m). Meanwhile, PPS has flagged additional investment in technology, product, sales and marketing to accelerate growth momentum. No quantification has been given, although this is a consistent theme from the company over the last two years. We note the recent hire (4 Oct) of a new Head of Product and Marketing. We make modest increases to our cost growth assumptions (see below) but generally we remain comfortable that our forecasts reflect the investment requirements of the business. Changes to EPS: We decrease our EPS forecasts by 1.5% and 0.5% in FY18F and FY19F respectively, adding $ m of investment which is largely offset by slightly better-thanexpected revenue momentum. Our $0.58 price target remains unchanged. Investment view: PPS continues to show good momentum across new business flows and funds under administration. We reiterate a BUY rating. Key attributes of our investment thesis include a growing managed accounts market as retail investor s switch from other fund structures; growth initiatives from higher margin products in international markets; new capabilities and scale following strategic acquisitions; and potential corporate appeal (wealth technology likely to be part of the next wave of financial service consolidation, in our view). The company s valuation is not demanding trading on an FY18F PE of 34x with a two-year EPS CAGR of 37%. From a relative perspective, PPS remains priced at the lower end of sector metrics, as shown in the table below. FIG.4: WEALTH PLATFORM SECTOR EV/Sales EV/EBITDA PE Adjusted YE Adjusted YE Adjusted YE Company Price YE FY18F FY19F FY18F FY19F FY18F FY19F Praemium 0.45 Jun HUB Jun Managed Accounts 0.31 Jun OneVue Holdings 0.58 Jun IRESS Ltd Dec Average Source: Bloomberg Baillieu Holst Ltd ABN Please read the disclaimer at the end of this report. Page 4
5 Appendix FIG.5: LONG TERM MOMENTUM INDICATORS Source: Iress FIG.6: SHORT TERM MOMENTUM INDICATORS Source: Iress Baillieu Holst Ltd ABN Please read the disclaimer at the end of this report. Page 5
6 This document has been prepared and issued by: Baillieu Holst Ltd ABN Australian Financial Service Licence No Participant of ASX Group Participant of NSX Ltd Analysts stock ratings are defined as follows: Buy: The stock s total return is expected to increase by at least percent from the current share price over the next 12 months. Hold: The stock s total return is expected to trade within a range of ±10-15 percent from the current share price over the next 12 months. Sell: The stock s total return is expected to decrease by at least percent from the current share price over the next 12 months. Baillieu Holst Analysts stock ratings distribution as of 05 September 2017: Buy: 64% Hold: 32% Sell: 4% Disclosure of potential interest and disclaimer: Baillieu Holst Ltd (Baillieu Holst) and/or its associates may receive commissions, calculated at normal client rates, from transactions involving securities of the companies mentioned herein and may hold interests in securities of the companies mentioned herein from time to time. Your adviser will earn a commission of up to 55% of any brokerage resulting from any transactions you may undertake as a result of this advice. When we provide advice to you, it is based on the information you have provided to us about your personal circumstances, financial objectives and needs. If you wish to rely on our advice, it is important that you inform us of any changes to your personal investment needs, objectives and financial circumstances. If you do not provide us with the relevant information (including updated information) regarding your investment needs, objectives and financial circumstances, our advice may be based on inaccurate information, and you will need to consider whether the advice is suitable to you given your personal investment needs, objectives and financial circumstances. Please do not hesitate to contact our offices if you need to update your information held with us. Please be assured that we keep your information strictly confidential. No representation, warranty or undertaking is given or made in relation to the accuracy of information contained in this advice, such advice being based solely on public information which has not been verified by Baillieu Holst Ltd. Save for any statutory liability that cannot be excluded, Baillieu Holst Ltd and its employees and agents shall not be liable (whether in negligence or otherwise) for any error or inaccuracy in, or omission from, this advice or any resulting loss suffered by the recipient or any other person. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a judgment at its original date of publication and are subject to change without notice. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise. The value of securities and financial instruments is subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of such securities or financial instruments. Baillieu Holst Ltd assumes no obligation to update this advice or correct any inaccuracy which may become apparent after it is given. Baillieu Holst Ltd ABN Australian Financial Service Licence No Participant of ASX Group Participant of NSX Ltd Melbourne (Head Office) Address Level 26, 360 Collins Street Melbourne, VIC 3000 Australia Postal PO Box 48, Collins Street West Melbourne, VIC 8007 Australia Phone Facsimile melbourne@baillieuholst.com.au Adelaide Office Address Ground Floor, 226 Greenhill Road, Eastwood SA 5063 Postal PO Box 171 Fullarton SA 5063 Phone Facsimile adelaide@baillieuholst.com.au Bendigo Office Address Level 1, Forest Street Bendigo, VIC 3550 Postal PO Box 84 Bendigo, VIC 3552 Phone Facsimile bendigo@baillieuholst.com.au Geelong Office Address 16 Aberdeen Street Geelong West Vic 3218 Postal PO Box 364 Geelong Vic 3220 Australia Phone Facsimile geelong@baillieuholst.com.au Gold Coast Office Address Suite 202 Level 2, Eastside Building 6 Waterfront Place, Robina QLD 4226 Phone Facsimile goldcoast@baillieuholst.com.au Newcastle Office Address Level 1, 120 Darby Street Cooks Hill, NSW 2300 Australia Postal PO Box 111 The Junction, NSW 2291 Australia Phone Facsimile newcastle@baillieuholst.com.au Perth Office Address Level 10, 191 St Georges Terrace Perth WA 6000 Australia Postal PO Box 7662, Cloisters Square Perth, WA 6850 Australia Phone Facsimile perth@baillieuholst.com.au Sydney Office Address Level 40, 259 George Street Sydney, NSW 2000 Australia Postal PO Box R1797 Royal Exchange, NSW 1225 Australia Phone Facsimile sydney@baillieuholst.com.au Baillieu Holst Ltd ABN Page 6
Praemium (PPS) COMPANY REPORT. Model performance
14 August 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.41 SNAPSHOT Monthly Turnover $9.5mn Market Cap $165mn Shares Issued 398.5mn 52-Week High $0.54 52-Week
More informationInsurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates
11 May 2018 RECOMMENDATIONS AUB Group (AUB) Rating HOLD Risk Low Price Target $14.50 Share Price $14.17 Steadfast Group (SDF) Rating HOLD Risk Low Price Target $2.80 Share Price $2.88 RESEARCH ANALYST
More informationAPN Outdoor Group (APO)
26 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating HOLD Risk Medium Price Target $6.70 Share Price $6.45 SNAPSHOT Monthly Turnover $323.7mn Market Cap $1,069mn Shares Issued 167.0mn 52-Week High $6.70 52-Week
More informationGenex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2
21 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $0.37 Share Price $0.31 SNAPSHOT Monthly Turnover $2.5mn Market Cap $91mn Shares Issued 303.9mn 52-Week High $0.43 52-Week
More informationFreedom Insurance (FIG)
03 November 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Medium Price Target $0.85 Share Price $0.50 SNAPSHOT Monthly Turnover $13.0mn Market Cap $169mn Shares Issued 239.7mn 52-Week High $0.97 52-Week
More informationVita Group (VTG) COMPANY REPORT. Vitality in question
18 May 2017 INTERNAL ONLY RECOMMENDATIONS Rating HOLD Risk High Price Target $0.85 Share Price $0.90 SNAPSHOT Monthly Turnover $79.4mn Market Cap $137mn Shares Issued 152.6mn 52-Week High $5.47 52-Week
More informationPacific Energy (PEA)
01 December 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.69 Share Price $0.58 SNAPSHOT Monthly Turnover $5.6mn Market Cap $223mn Shares Issued 371.8mn 52-Week High $0.77 52-Week
More informationSeaLink Travel Group (SLK)
29 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Medium Price Target $5.10 Share Price $4.45 SNAPSHOT Monthly Turnover $9.3mn Market Cap $446mn Shares Issued 101.2mn 52-Week High $4.46 52-Week
More informationAppen (APX) COMPANY REPORT
11 January 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $10.00 Share Price $8.63 SNAPSHOT Monthly Turnover $89.8mn Market Cap $895mn Shares Issued 105.8mn 52-Week High $8.96 52-Week
More informationBass Metals (BSM) COMPANY REPORT INITIATION OF COVERAGE. Starting small in graphite
6 February 218 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $.7 Share Price $.2 SNAPSHOT Monthly Turnover $5.4mn Market Cap $46mn Shares Issued 2,213.4mn 52-Week High $.3 52-Week
More informationGold Road Resources (GOR)
24 November 215 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $.47 Share Price $.37 SNAPSHOT Monthly Turnover $6.7mn Market Cap $26mn Shares Issued 693.5mn 52-Week High $.48 52-Week
More informationAustralian Strategy Insight
21 March 218 INTERNAL ONLY CHIEF INVESTMENT OFFICER Malcolm Wood +61 2 925 8916 mwood@baillieuholst.com.au Australian Strategy Insight INVESTMENT STRATEGY US starting to outstrip Australia Over the past
More informationKibaran Resources (KNL)
26 March 218INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $.23 Share Price $.13 SNAPSHOT Monthly Turnover $.4mn Market Cap $32mn Shares Issued 244.4mn 52-Week High $.21 52-Week
More informationPacific Energy (PEA)
11 August 2016 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.73 Share Price $0.64 SNAPSHOT Monthly Turnover $2.1mn Market Cap $235mn Shares Issued 370.2mn 52-Week High $0.65 52-Week
More informationAustralian Equity Research
8 March 2018 Australian Equity Research MARCH 2018 Top Stock Picks Mid & Small Caps Overall: We select the top picks from our 86 mid and small cap universe, as well as the outlook for the economy and equity
More informationAsset Allocator INVESTMENT STRATEGY. Extreme Underweight
27 June 2018 INTERNAL ONLY CHIEF INVESTMENT OFFICER Malcolm Wood +61 2 9250 8916 mwood@baillieuholst.com.au Asset Allocator INVESTMENT STRATEGY Reducing Australian equities; adding to International Year-to-date
More informationHybrids Daily. Commentary on yesterday s market FIG.1: UP FIG.2: DOWN FIG.3: BEST SWITCH FIG.4: UPCOMING DISTRIBUTIONS FIG.5: THE SWAP CURVE 2.
Interest Rate BAILLIEU HOLST RESEARCH 13 April 2016 INTERNAL ONLY Hybrids Daily Commentary on yesterday s market Business conditions have soared to the highest level in eight years, according to NAB, with
More informationHybrids Daily. Commentary on yesterday s market FIG.1: UP FIG.2: DOWN FIG.3: BEST SWITCH FIG.4: UPCOMING DISTRIBUTIONS FIG.5: THE SWAP CURVE 3.
Interest Rate BAILLIEU HOLST RESEARCH 30 June 2016 INTERNAL ONLY Hybrids Daily Commentary on yesterday s market Germany's financial market regulator has delivered a double blow to London, saying it could
More informationZip Co. Delivering against expectations. Last Price A$0.86 Target Price A$0.90 (Previously A$0.88) Recommendation Accumulate Risk Higher.
Delivering against expectations Z1P s Mar-18 qtrly report delivered well against our expectations. Positive operating cash flow for the qtr of $1.6m was a +$2.8m improvement qoq, despite the receivables
More informationBUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS
BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD
More informationCompany Review 1300SMILES. Corporate Activity Dental Partners. ONT A$6.72 (TP $6.26) Recommendation Hold (no change) Risk Assessment Medium
Ord Minnett Research 2 October 2013 1300SMILES Corporate Activity Dental Partners Event: A consortium led by private equity firm, Archer Capital has recently made an indicative offer for 100% of New Zealand
More informationOneVue Holdings (OVH)
24 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation Peter Arden 613 9235 1833 OneVue Holdings (OVH) Restructured and focused Recommendation Buy (unchanged) Price $0.745 Target (12 months)
More informationNoni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts
Date Theme Company Update Company Noni B (NBL) SFH acquisition could be up to 6 EPS accretive Press reports today (Australian) suggest Noni B is a potential acquirer of Specialty Fashion Group (SFH), in
More informationCompany Review. Centaurus Metals. Jambreiro Resource upgrade. CTM A$0.08 Recommendation Buy Risk Assessment High
Company Review Ord Minnett Research Friday, June 24, 2011 Centaurus Metals Jambreiro Resource upgrade Centaurus has upgraded the JORC resource at its flagship, Jambreiro Iron Ore Project in Brazil. The
More informationZip Co. Improved medium term cost guidance. Last Price A$0.96 Target Price A$1.00 (Previously A$0.90) Recommendation Accumulate Risk Higher
Improved medium term cost guidance Z1P s Jun-18 qtrly update outlined a beat against our cash flow expectations, with the company having generated positive operating cash flow (after bad debts) for the
More informationConsolidated Operations Group (COG)
Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation
More informationOneVue Holdings (OVH)
7 August 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 OneVue Holdings (OVH) FY17 result to show cost-out progress Recommendation
More informationWisr Ltd (DirectMoney)
Wisr Ltd (DirectMoney) Strategic placement at 56% premium to previous close Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace lending sector. The
More informationWisr Ltd (DirectMoney)
Wisr Ltd (DirectMoney) Interim result draws a line in the sand Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace-lending sector. The company has
More informationMotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts
Date Theme Company Update Company MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction We moderate to HOLD (from Buy) with a revised target of $2.36 p/share. We were previously encouraged
More informationResetting expectations
Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp
More informationAsset revaluation driven by almonds
Company update 20 July 2015 RURAL FUNDS GROUP (RFF) Asset revaluation driven by almonds We retain a BUY rating with a 12-month target of $1.15 p/unit. RFF is a listed property trust with a portfolio of
More informationPerpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions
16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously
More informationManaged Accounts Holdings
Managed Accounts Holdings MGP.ASX BUY Realised synergies drives profit above expectations The Underlying EBITDA exceeded the upper end of previous guidance, with continued organic growth and initial integration
More informationMacPhersons Resources (MRP)
07 May 2012 RECOMMENDATIONS Rating BUY Risk Very High Price Target $0.59 Share Price $0.40 SNAPSHOT Monthly Turnover $3.1mn Market Cap $85mn Shares Issued 215mn 52-Week High $0.41 52-Week Low $0.23 Sector
More informationMNF Group Limited (MNF)
MNF Group Limited (MNF) 16 February 2018 Outperform 1H18 Results: Excessive Sell-off Presents Buying Opportunity $5.14 Chris Reindler creindler@taylorcollison.com.au +61 2 9210 1335 Summary (AUD) Market
More informationListed Investment Companies (LICs)
21 March 218 CONTENTS Company Page # LIC Sector Picks 1 Updated Sector Snapshot 2 LIC Table 3 Top Picks AFIC (AFI) 4 Diversified United (DUI) 5 WAM Leaders (WLE) 6 Acorn Capital (ACQ) 7 Templeton Global
More informationBoart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation
AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index
More informationNoni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts
Date 09 January 2018 Theme Company Update Company Noni B (NBL) BUY: FY18e EBITDA +12.8% NBL provided a positive 1H18 trading update today, advising LFL sales growth of 3.0% (1.5% in 1H17) and EBITDA of
More informationPort of Tauranga. Investor Day update. Investor Day focuses on competitive advantages. Forecast revisions; EPS changes are immaterial (Fig 4)
Australasia New Zealand Emerging Companies Institutional Research Company Update Reuters Bloomberg Exchange Ticker 30 November 2011 Issued by: Craigs Investment Partners Ltd Hold POT.NZ POT NZ NZE POT
More informationWisr Ltd. New products to underpin growth
Wisr Ltd Company Update New products to underpin growth Wisr Limited (WZR.AX) is an online consumer lending platform focused on financial wellness and competing in the rapidly growing marketplace lending
More informationPlatinum Asset Management (PTM)
24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90
More informationSG Fleet Group. Another UK acquisition. Earnings and target price revision
AUSTRALIA SGF AU Price (at 08:26, 30 Nov 2016 GMT) Outperform A$3.23 Valuation - PER A$ 3.96-4.22 12-month target A$ 4.37 12-month TSR % +41.0 Volatility Index High GICS sector Commercial & Professional
More informationIOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.
AUSTRALIA IFL AU Price (at 06:35, 26 Oct 2016 GMT) Outperform A$8.34 Valuation A$ - DCF (WACC 8.8%, beta 1.1, ERP 5.0%, RFR 3.3%) 8.74 12-month target A$ 9.00 12-month TSR % +14.3 Volatility Index Low/Medium
More informationAventus Retail Property Fund
AUSTRALIA AVN AU Price (at 06:10, 29 Apr 2016 GMT) A$2.16 Volatility Index Low GICS sector Real Estate Market cap A$m 741 30-day avg turnover A$m 0.7 Number shares on issue m 343.2 Investment fundamentals
More informationCardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA CDD AU Price (at 04:53, 17 Feb 2015 GMT) Neutral A$2.88 Valuation - Sum of Parts A$ 2.80-3.43 12-month target A$ 3.12 12-month TSR % +18.4 Volatility Index Medium GICS sector Capital Goods Market
More informationVista Group International
NEW ZEALAND VGL NZ Price (at 03:15, 26 Feb 2015 GMT) Outperform NZ$4.35 Valuation NZ$ 4.31 - DCF (WACC 9.9%, beta 1.0, ERP 7.0%, RFR 4.0%, TGR 2.0%) 12-month target NZ$ 4.75 12-month TSR % +9.5 Volatility
More informationAtCor Medical Holdings Limited (ACG)
Volume (million) AtCor Medical Holdings Limited (ACG) 30 March 2015 Speculative Buy Value Creation Ahead Post CPT1 Code Award $0.20 Marcus Hamilton mhamilton@taylorcollison.com.au +61 2 9210 1317 Summary
More informationWINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW
WINDLAB LTD HOLD Lakeland financial close delayed again. Downgrade to HOLD. Utilities / Renewable Electricity 7 November 2018 COMPANY UPDATE Ticker WND Stock Price $1.180 Target Price $1.350 Forecast Capital
More informationSPS Managed Portfolios Aust Equities Income Portfolio
SPS Managed Portfolios Aust Equities Income Portfolio For further information on Baillieu Holst s Discretionary SPS Managed Portfolios, contact your adviser or email your details to Strategic Planning
More informationCENTREPOINT ALLIANCE LIMITED (CAF)
Low Return High Financial Results 25 August 2014 CENTREPOINT ALLIANCE LIMITED (CAF) ACTION & RECOMMENDATION Financial planning and SME insurance premium funding business Centrepoint Alliance (ASX code:
More informationRegional Express Holdings Ltd REX
20 February 2006 REX $1.15 Analyst Ken Fleming (613) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (613) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$132.3M Performance & Valuation Last
More informationInvocare. Well-positioned. Earnings and target price revision. Price catalyst. Catalyst: FY12 results. Action and recommendation
AUSTRALIA IVC AU Close Price* 19 Jan 12 Outperform A$7.54 Volatility index Low 12-month target A$ 8.3 12-month TSR % +14.6 Valuation A$ 8.28 - DCF GICS sector Consumer Services Market cap A$m 83 3-day
More informationRecycling assets at a premium. Vector to sell non-auckland gas assets at a premium. We view the transaction as value accretive
Australasia New Zealand Utilities Institutional Research Breaking News Reuters Bloomberg Exchange Ticker VCT.NZ VCT NZ NZE VCT Recycling assets at a premium 9 November 015 Issued by: Craigs Investment
More informationAPN Property Group (APD) Buy Share Price: A$0.41
APN Property Group (APD) Buy Share Price: A$0.41 Success in direct syndicates Target Price: A$0.51 Direct property syndicates have always been an integral part of the APN Property Group (APD) business.
More informationAdacel Technologies (ADA)
9 November 2018 Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Adacel Technologies (ADA) Bad, but not that bad Recommendation Buy (unchanged) Price $0.88 Target (12 months) $1.50 (previously
More informationResults Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013
Results Review (Member of Alliance Bank group) PP7766/03/2013 (032116) 8 November 2013 Analyst Toh Woo Kim wookim@alliancefg.com +603 2604 3917 12-month upside potential Previous target price 0.89 Revised
More informationSims Metal Management
AUSTRALIA SGM AU Price (at 5:11, 17 Nov 215 GMT) Outperform A$7.19 Valuation - EV/EBIT A$ 8.49-9.6 12-month target A$ 8.9 12-month TSR % +26.6 Volatility Index Medium GICS sector Materials Market cap A$m
More informationManaged Accounts Holdings
Managed Accounts Holdings MGP.ASX BUY Acquisition of Linear Financial (Linear) MGP has merged with Linear, with MGP paying an Enterprise Value of $42.5m, split: $14.0m in MGP scrip, comprising 42.4m shares
More informationEarnings and target price revision. Price catalyst. Action and recommendation
AUSTRALIA TLS AU Price (at 13:07, 19 Apr 2012 GMT) Outperform A$3.39 Volatility index Low 12-month target A$ 3.55 12-month TSR % +13.0 Valuation A$ - DCF (WACC 9.6%, beta 0.9, ERP 6.0%, TGR 1.0%) 3.55
More informationPlatinum Asset Management
AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium
More informationFor personal use only 1H17 RESULTS PRESENTATION
For personal use only 1H17 RESULTS PRESENTATION KEY PERFORMANCE METRICS FOR 1H17 OPERATIONAL FINANCIAL CAPITAL MANAGEMENT 1,408 settlements Up 10% $19.8m 1H17 operating profit after tax Up 7% 24.8% gearing
More informationCash Converters Intl.
MICROCAP COMPANY RESEARCH Cash Converters Intl. 22 nd November 2012 GICS: Diversified Financials Consumer Finance 1Q13 Trading Update RECENT NEW S Cash Converters [ASX:CCV] recently provided a trading
More informationSG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.
AUSTRALIA SGF AU Price (at 07:57, 27 Oct 2016 GMT) Outperform A$3.85 Valuation - PER A$ 3.92-4.18 12-month target A$ 4.37 12-month TSR % +18.1 Volatility Index Medium GICS sector Commercial & Professional
More informationGeneration Healthcare REIT
AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap
More informationHCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.
Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully
More informationCompany Review. Horizon Oil Limited (HZN) FY14 results full year China impact. Last price $0.34
Ord Minnett Research 1 September (HZN) FY14 results full year China impact Valuation and Recommendation We retain our Buy recommendation and have revised our target price to $0.45/sh (prev. $0.53/sh) after
More informationSomnoMed (SOM) BUY: US channel conflicts abating in Q4. Key points. Risks and catalysts
Date 27 April 2017 Theme Company Update Company SomnoMed (SOM) BUY: US channel conflicts abating in Q4 We maintain a BUY rating and 12-month price target of $4.50 per share. SomnoMed s Q3 update was a
More informationMEDICAL DEVELOPMENTS INTERNATIONAL LTD
MEDICAL DEVELOPMENTS INTERNATIONAL LTD No pain in Germany HOLD Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals 6 April 2018 COMPANY UPDATE Ticker MVP Stock Price $7.10 Target Price $8.08
More informationAustralian Banks. If it s too good to be true AUSTRALIA. Event. Impact. Outlook. Impact of repricing and capital from additional 10% investor RWA
CBA CBA CBA CBA AUSTRALIA Changes to lending rates (bps) bps Owner Occupier Investor P&I IO P&I IO 0 20 25 36 CBA 3 25 24 26 7 7 25 25 3 8 23 28 BEN 0 0 25 25 Source: Company data, Macquarie research,
More informationFund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views
AUSTRALIA 4 February 2016 Macquarie Securities (Australia) Limited Aust. Fund managers review & rank Event We review and rank the listed Australian under Macquarie Securities coverage, assessing fund performance,
More informationCOMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW
COMPUMEDICS LTD HOLD CMP Downgrades FY17 Guidance Health Care Equipment & Services / Health Care Equipment 7 July 2017 COMPANY UPDATE Ticker CMP Stock Price $0.560 Target Price $0.530 Forecast Capital
More informationFLASH NOTE Welspun India 31 Jan 17
Oct-11 Feb-12 Jun-12 Oct-12 Feb-13 Jun-13 Oct-13 Feb-14 Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 FLASH NOTE Welspun India 31 Jan 17 CMP (Rs) 76 TP (Rs) 81 Outperformer Key Figures
More informationNanosonics (NAN) 1H17: Cash earnings beat grabs attention. Key points
Date 21 February 2017 Theme Financial Results Company Nanosonics (NAN) 1H17: Cash earnings beat grabs attention We maintain our BUY rating with a revised price target of $3.72 per share. NAN shares have
More informationFor personal use only
IMPORTANT NOTICE AND DISCLAIMER Important notice and disclaimer This document is a presentation of general background information about the activities of Mantra Group Limited (Mantra Group) current at
More informationAuckland International Airport
NEW ZEALAND AIA NZ Price (at 04:00, 27 Nov 2013 GMT) Neutral NZ$3.42 Valuation NZ$ 3.37 - DCF (WACC 8.0%, beta 0.9, ERP 7.0%, RFR 4.3%, TGR 3.0%) 12-month target NZ$ 3.37 12-month TSR % +2.6 Volatility
More informationRajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer
Monday, February 4, 2019 www.evaluateresearch.com Target Price Rs. 900.00 Current Price Rs. 598.00 Upside Potential 50% Market Cap. Shares Outstanding Rs. 176,802 mn US$ 2.47 bn 295.3 mn Free Float (FF
More informationONEVIEW HEALTHCARE PLC
ONEVIEW HEALTHCARE PLC BUY 2017 Result Green Shoots Emerging Health Care Equipment & Services / Health Care Technology 28 February 2018 COMPANY UPDATE Ticker ONE Stock Price $1.900 Target Price $3.04 Forecast
More informationUGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation
AUSTRALIA AU Price (at 08:17, 03 Sep 2012 GMT) Underperform A$10.52 Volatility index Low 12-month target A$ 11.08 12-month TSR % +12.0 Valuation A$ - DCF (beta 1.1, ERP 5.0%, RFR 6.0%, TGR 2.5%) 15.09
More informationChallenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation
1H13E 2H13E 1H14E 2H14E 1H15E 2H15E AUSTRALIA CGF AU Price (at CLOSE#, 20 Aug 2012) Outperform A$3.76 Volatility index Low 12-month target A$ 4.57 12-month TSR % +26.4 Valuation - Sum of Parts A$ 4.57
More information22 February 2018 Ian Munro
22 February 2018 Ian Munro imunro@ccz.com.au 03 8605 7902 Recommendation: BUY, target price $0.43 (from $0.50) Share price: $0.36 Market cap: $103.7m Year end June 2016A 2017A 2018E 2019E 2020E Sales ($m)
More informationPinnacle Investment Management
The pinnacle of execution Pinnacle provided a FUM update and 1H18 guidance which were both well ahead of our expectation, driven by rapid retail and insto inflows. FUM at Dec-17 of $32.4b sits above our
More informationPRICE $1.30 Regional Express Holdings Ltd REX
16 November 2006 PRICE $1.30 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115M Market cap A$133M
More informationSlater & Gordon Limited
BBY Company Research 29 November 2013 Slater & Gordon Limited SGH A$4.39 TARGET PRICE A$5.00 BUY 0.5X Slater & Gordon Limited (SGH) is a national law firm. The Firm's areas of practice include commercial,
More informationCooks Global Foods Ltd
Cooks Global Foods Ltd Company Update Gaining traction, restructure taking time Cooks Global Foods (CGF.NZAX) is a global integrated food and beverage retail and supply company headquartered in New Zealand.
More informationChina Renewable Energy Investment Ltd (987_HK)
Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9
More informationSomnoMed (SOM) An eye on RSS channel conflict but the core offering to prevail in US direct market. Key points. Risks and catalysts
Date 24 February 2017 Theme Financial Results Company SomnoMed (SOM) An eye on RSS channel conflict but the core offering to prevail in US direct market We maintain a BUY rating and 12-month price target
More information2014 E 2015 E 2016 E 2017 E
Equity Research 4 December 2014 Interpump Group Hydraulics M&A may power growth Rating BUY Target price EUR13 Interpump is up 25% since the beginning of the year, bolstered by strong interim results and
More informationNanosonics (NAN) BUY: Nanosonics investing in its next phase. Key points. Risks and catalysts
Date 28 August 2017 Theme Financial Results Company Nanosonics (NAN) BUY: Nanosonics investing in its next phase We maintain our BUY rating with a revised price target of $3.10 per share. Nanosonics FY17
More informationCodan Ltd (CDA) EQUITY RESEARCH Information Technology. Solid first half momentum, positioned for even better second.
Feb 17 Mar 17 Apr 17 May 17 Jul 17 Aug 17 Sep 17 Oct 17 Nov 17 Dec 17 Jan 18 Feb 18 EQUITY RESEARCH Information Technology 26 February 2018 Codan Ltd (CDA) Solid first half momentum, positioned for even
More informationWestoz Investment Company. October 2018
Westoz Investment Company October 2018 Disclaimer Disclaimer & Disclosure Westoz Investment Company Limited ACN 113 332 942 (WIC) and Westoz Funds Management Pty Ltd (WFM) AFSL 85607, their related entities
More informationZespri. Vote for change and SunGold licence sales underpin a strong outlook COMPANY RESEARCH. Private Wealth Research
COMPANY RESEARCH 8 MAY 218 Private Wealth Research Zespri Vote for change and SunGold licence sales underpin a strong outlook Key data Code Current price ZGL NZ$8.7 Over the past 6 months since our initiation
More informationPRICE $1.16 Regional Express Holdings Ltd REX
13 September 2006 PRICE $1.16 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$121.9M
More informationDongfang Modern Agriculture (DFM)
Raising Orange Prices to Drive Up Profitability 4 October 2017 Paul Jensz pjensz@pacpartners.com.au +61 3 8633 9864 Key Points Recommendation Spec. Buy DFM has managed to secure another ~920 hectares of
More informationIntershop Communications AG
FIRST BERLIN Equity Research Intershop Communications AG RATING GERMANY / Technology Primary Exchange: Frankfurt Q2 figures PRICE TARGET 1.44 Bloomberg: ISH2 GR Return Potential -15.2% ISIN: DE000A0EPUH1
More informationPrime Financial Group Ltd (ASX: PFG) Full Year 2018 Results Presentation
Prime Financial Group Ltd (ASX: PFG) Full Year 2018 Results Presentation 29 August 2018 Click here to access accompanying Full Year 2018 Results Presentation podcast Key Points 1. Exposure to favourable
More informationYansab Better than expected results
YANSAB AB: Saudi Arabia US$6.91bn 39.8% US$23.37mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 56.00 21.5% over current Current price 46.10 as at 9/2/2011
More informationDowner EDI Two out of three ain t bad Event
AUSTRALIA DOW AU Price (at 06:26, 01 Dec 2016 GMT) Outperform A$6.08 Valuation - Sum of Parts A$ 5.69-6.38 12-month target A$ 6.40 12-month TSR % +9.6 Volatility Index Medium GICS sector Commercial & Professional
More informationNanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research
LINWAR Securities 30 August 2011 Nanosonics Limited Australia Health Care Equipment & Supplies Outperform (Unchanged) Price: Target Price: Stock's expected return (12mth) $0.57 $1.20 Capital growth 112.4%
More informationTabcorp Holdings Limited. 2014/15 Full Year Results Presentation 13 August 2015
Tabcorp Holdings Limited ABN 66 063 780 709 2014/15 Full Year Results Presentation 13 August 2015 Draft version 15 (01-08-13) FY15 overview Statutory NPAT $334.5m, up 157.5%, comprising of: NPAT from continuing
More information